|
Volumn 111, Issue 4, 2001, Pages 270-273
|
Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DALTEPARIN;
WARFARIN;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
CANCER;
CANCER MORTALITY;
CAUSE OF DEATH;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
DISEASE ASSOCIATION;
DISEASE PREDISPOSITION;
HUMAN;
LONG TERM CARE;
LUNG EMBOLISM;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SURVIVAL;
SYMPTOMATOLOGY;
THROMBOEMBOLISM;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
FEMALE;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
OUTPATIENTS;
RECURRENCE;
RETROSPECTIVE STUDIES;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
WARFARIN;
|
EID: 0034833886
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(01)00840-3 Document Type: Article |
Times cited : (75)
|
References (15)
|